We are live on ! Find out more
CRM

Cramer Rosenthal McGlynn Portfolio holdings

AUM $1.36B
1-Year Est. Return 31.72%
This Fund
S&P 500
This Quarter Est. Return
-16.44%
1 Year Est. Return
+31.72%
3 Year Est. Return
+70.83%
5 Year Est. Return
+96.16%
10 Year Est. Return
+415.48%
AUM
$3.96B
AUM Growth
-$1.27B
Cap. Flow
-$350M
Cap. Flow %
-8.84%
Top 10 Hldgs %
21.71%
Holding
152
New
15
Increased
37
Reduced
72
Closed
16

Sector Composition

Rank Sector Weight
1 Industrials 16.91%
2 Financials 16.29%
3 Technology 15.47%
4 Consumer Discretionary 9.73%
5 Healthcare 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCP
26
DELISTED
GCP Applied Technologies Inc.
GCP
$52.1M 1.32%
2,121,029
-36,979
-2% -$950K
THS
27
DELISTED
Treehouse Foods
THS
$50.1M 1.27%
987,164
+98,289
+11% +$4.85M
ATO icon
28
Atmos Energy
ATO
$29.9B
$49.7M 1.26%
535,752
+22,620
+4% +$2.16M
AVGO icon
29
Broadcom
AVGO
$1.81T
$49M 1.24%
1,926,150
-752,930
-28% -$17.8M
AIG icon
30
American International
AIG
$42.9B
$48.4M 1.22%
1,227,612
+275,243
+29% +$12M
PRMW
31
DELISTED
Primo Water Corporation
PRMW
$46.6M 1.18%
3,343,582
+284,886
+9% +$4.19M
BIO icon
32
Bio-Rad Laboratories Class A
BIO
$8.86B
$46.6M 1.18%
200,656
+13,798
+7% +$3.7M
EQC
33
DELISTED
Equity Commonwealth
EQC
$46.3M 1.17%
1,542,324
-18,112
-1% -$552K
AGN
34
DELISTED
Allergan plc
AGN
$44.8M 1.13%
334,898
-118,625
-26% -$19.4M
RGS icon
35
Regis Corp
RGS
$68.2M
$42.7M 1.08%
126,020
+29,737
+31% +$10.6M
CSX icon
36
CSX Corp
CSX
$94.2B
$42.5M 1.07%
2,051,394
-772,038
-27% -$17.8M
THG icon
37
Hanover Insurance
THG
$7.84B
$42.4M 1.07%
362,788
-21,374
-6% -$2.4M
FANG icon
38
Diamondback Energy
FANG
$53.5B
$40.5M 1.02%
+436,669
New +$48.8M
NDAQ icon
39
Nasdaq
NDAQ
$53.6B
$40.1M 1.01%
1,473,075
-50,103
-3% -$1.43M
XYL icon
40
Xylem
XYL
$29.7B
$38.6M 0.97%
577,942
-33,542
-5% -$2.32M
CLH icon
41
Clean Harbors
CLH
$16B
$37M 0.94%
750,040
-596,155
-44% -$37.1M
INFO
42
DELISTED
IHS Markit Ltd. Common Shares
INFO
$36.3M 0.92%
757,735
-420,471
-36% -$21.5M
HMHC
43
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$36M 0.91%
4,063,731
-675,794
-14% -$5.34M
MTN icon
44
Vail Resorts
MTN
$5.6B
$35.8M 0.91%
170,034
+20,309
+14% +$5.02M
COO icon
45
Cooper Companies
COO
$14.1B
$35.2M 0.89%
553,016
-139,372
-20% -$9.02M
DD icon
46
DuPont de Nemours
DD
$19B
$34.6M 0.87%
255,267
-202,058
-44% -$29M
ELV icon
47
Elevance Health
ELV
$83.7B
$34M 0.86%
129,389
+102,549
+382% +$28.2M
AWK icon
48
American Water Works
AWK
$27B
$33.7M 0.85%
371,435
-24,281
-6% -$2.22M
NEE icon
49
NextEra Energy
NEE
$186B
$33.5M 0.85%
771,920
+139,060
+22% +$6.08M
CADE
50
DELISTED
Cadence Bank
CADE
$32.1M 0.81%
1,227,418
-66,850
-5% -$1.94M

Similar funds

Cramer Rosenthal McGlynn's Q4 2018 Portfolio in Review

As of Q4 2018, Cramer Rosenthal McGlynn held 152 positions worth $3.96B, down 24% from $5.23B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Cramer Rosenthal McGlynn withdrew a net $350M in Q4 2018, closing 16 positions and reducing 72 holdings. Its most notable exit was Energen, an estimated $63.9M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Financials and Technology.

Against the trend, Cramer Rosenthal McGlynn opened a new position in Terminix Global Holdings, Inc. worth $61.3M.

  • Cramer Rosenthal McGlynn's largest Q4 2018 buy was Terminix Global Holdings, Inc.: 1,667,762 shares worth $61.3M.
  • Cramer Rosenthal McGlynn added most to Carlisle Companies in Q4 2018, an estimated $92.3M increase.
  • Cramer Rosenthal McGlynn's biggest Q4 2018 reduction was Boston Private Financial Holdings, Inc., cutting an estimated $51.8M.
  • Cramer Rosenthal McGlynn fully exited Energen in Q4 2018, selling an estimated $63.9M.
  • Cramer Rosenthal McGlynn's ten largest holdings make up 22% of its $3.96B portfolio in Q4 2018.
  • Cramer Rosenthal McGlynn opened 15 new positions and closed 16 in Q4 2018.
  • Cramer Rosenthal McGlynn's portfolio value fell 24% quarter-over-quarter to $3.96B.

Based on Cramer Rosenthal McGlynn's 13F filing for Q4 2018, filed 13 Feb 2019.